Page 18 - 2017 AMETEK Annual Report (Interactive) Updated mobile
P. 18

Financial Review


          Management’s Discussion and Analysis



          This 2017 summary annual report contains abbreviated    compared with international sales of $2,010.7 million or
          financial information. The complete text of Management’s   52.4% of net sales in 2016. The $203.3 million increase in
          Discussion and Analysis of Financial Condition and Results   international sales was primarily driven by organic sales
          of Operations and the consolidated financial statements   growth. Both reportable segments of the Company maintain
          and footnotes are presented in AMETEK’s 2017 Form 10-K   strong international sales presences in Europe and Asia.
          and in Appendix A to the Company’s Proxy Statement for
          the 2018 Annual Meeting of Stockholders.                Orders for 2017 were $4,539.8 million, an increase of
                                                                  $691.0 million or 18.0%, compared with $3,848.8 million
          Business Overview                                       in 2016. The increase in orders for 2017 was due to 10%
          AMETEK’s operations are affected by global, regional    organic order growth, a 6% increase from acquisitions
                                                                  and favorable 2% effect of foreign currency translation.
          and industry economic factors. However, the Company’s   As a result, the Company’s backlog of unfilled orders at
          strategic geographic and industry diversification, and its   December 31, 2017 was a record $1,396.1 million, an
          mix of products and services, have helped to mitigate the   increase of $239.6 million or 20.7%, compared with
          potential adverse impact of any unfavorable developments   $1,156.5 million at December 31, 2016.
          in any one industry or the economy of any single country on
          its consolidated operating results. The strengthening global   The Company recorded 2017 realignment costs totaling
          economic environment compared to 2016, contributions    $16.8 million in the fourth quarter of 2017 (the “2017
          from recent acquisitions, and continued focus on and    realignment costs”). The 2017 realignment costs were
          implementation of Operational Excellence initiatives, had   composed of $3.0 million in severance costs for a
          a positive impact on 2017 results. In 2017, the Company   reduction in workforce, $7.8 million of asset write-downs
          established records for orders, sales, operating income, net   and $6.0 million in costs to withdraw from a multiemployer
          income, diluted earnings per share and operating cash flow.   defined benefit pension plan. The 2017 realignment costs
          The continued strengthening global economic environment,   better position the Company’s long-term cost structure and
          contributions from recent acquisitions and continued focus   included costs associated with the continued consolidation
          on and implementation of Operational Excellence initiatives,   of the Company’s floor care and specialty motors
          including the 2017 and 2016 realignment actions (described   businesses into its precision motion control businesses.
          further throughout), are expected to have a positive impact   The Company recorded 2016 realignment costs totaling
          on the Company’s 2018 results.                          $25.6 million in the fourth quarter of 2016 (the “2016
                                                                  realignment costs”). The 2016 realignment costs primarily
          The table on the opposite page sets forth net sales     related to $19.3 million in severance costs for a reduction in
          and operating income for the Company by business        workforce and $6.2 million of asset write-downs in response
          segment and on a consolidated basis for the years ended   to the impact of a weak global economy on certain of the
          December 31, 2017, 2016 and 2015. The discussion that   Company’s businesses, as well as the effects of a continued
          follows should be read in conjunction with the condensed   strong U.S. dollar. Also, in the fourth quarter of 2016, the
          consolidated financial statements appearing elsewhere in   Company recorded a $13.9 million noncash impairment
          this summary annual report.
                                                                  charge related to certain of the Company’s trade names.
          Review of Operations                                    The 2017 and 2016 realignment costs and 2016 impairment
          Net sales for 2017 were $4,300.2 million, an increase   charge were reported in the consolidated statement of
          of $460.1 million or 12.0%, compared with net sales of   income as follows (in millions):
                                                                                                         Year Ended
          $3,840.1 million in 2016. The increase in net sales for 2017                                  December 31,
          was due to 6% organic sales growth and a 6% increase                                          2017  2016
          from acquisitions. EIG net sales were $2,690.6 million in   Realignment costs                  $ 16.8    $ 24.0
          2017, an increase of 14.0%, compared with $2,360.3 million   Impairment charge                   —    13.9
          in 2016. The EIG net sales increase for 2017 was due to        Cost of sales                      16.8       37.9
          a 9% increase from the 2017 acquisitions of MOCON and
          Rauland and 2016 acquisitions of Nu Instruments, Brookfield   Realignment costs                        —        1.6
          and ESP/SurgeX, and 5% organic sales growth. EMG net    Impairment charge                            —         —
          sales were $1,609.6 million in 2017, an increase of 9%,        Selling, general and administrative expenses        —       1.6
          compared with $1,479.8 million in 2016. The EMG net sales
          increase for 2017 was due to 8% organic sales growth and a   Realignment costs                    16.8       25.6
          1% increase from the 2016 acquisition of Laserage.      Impairment charge                          —      13.9
                                                                     Total reported in the consolidated statement of income    $ 16.8    $ 39.5
          Total international sales for 2017 were $2,214.0 million or
          51.5% of net sales, an increase of $203.3 million or 10.1%,
          16
   13   14   15   16   17   18   19   20   21   22   23